Kristian Humer

Director, Faeth Therapeutics, Inc.

Companies

4D Molecular Therapeutics, Inc.Chief financial officer Dec 11, 2025 to now¹
Faeth Therapeutics, Inc.Board member Aug 2, 2021 to now²
Foghorn Therapeutics Inc.Chief financial officer Apr 17, 2024 to Feb 24, 2026³
Viridian Therapeutics, Inc.\DEChief financial officer Jul 27, 2021 to Feb 10, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Faeth Therapeutics, Inc. FTH8,932 shares⁵$184.0K at $20.60Jul 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 10, 2023Granted 4,466 shares of Faeth Therapeutics, Inc.⁵
Jun 10, 2022Granted 4,466 shares of Faeth Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAR4D Molecular Therapeutics, Inc., Chief financial officer
2
SEC EDGARFaeth Therapeutics, Inc., Board member
3
SEC EDGARFoghorn Therapeutics Inc., Chief financial officer
4
SEC EDGARViridian Therapeutics, Inc.\DE, Chief financial officer
5
SEC EDGARFaeth Therapeutics, Inc. shares after the filing of Jul 10, 2023
6
SEC EDGARForm 4 filed Jun 14, 2022